USANA Health Sciences, Inc. $USNA Shares Purchased by AlphaQuest LLC

AlphaQuest LLC raised its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 300.9% during the first quarter, Holdings Channel.com reports. The institutional investor owned 3,412 shares of the company’s stock after buying an additional 2,561 shares during the period. AlphaQuest LLC’s holdings in USANA Health Sciences were worth $92,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the business. Pzena Investment Management LLC boosted its holdings in shares of USANA Health Sciences by 0.7% during the first quarter. Pzena Investment Management LLC now owns 1,095,186 shares of the company’s stock worth $29,537,000 after purchasing an additional 8,110 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of USANA Health Sciences by 7.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company’s stock worth $27,751,000 after purchasing an additional 55,059 shares during the last quarter. American Century Companies Inc. boosted its holdings in shares of USANA Health Sciences by 9.2% during the first quarter. American Century Companies Inc. now owns 255,242 shares of the company’s stock worth $6,884,000 after purchasing an additional 21,445 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of USANA Health Sciences by 23.5% during the first quarter. Charles Schwab Investment Management Inc. now owns 173,997 shares of the company’s stock worth $4,693,000 after purchasing an additional 33,141 shares during the last quarter. Finally, Northern Trust Corp boosted its holdings in shares of USANA Health Sciences by 16.5% during the fourth quarter. Northern Trust Corp now owns 135,937 shares of the company’s stock worth $4,879,000 after purchasing an additional 19,266 shares during the last quarter. Institutional investors and hedge funds own 54.25% of the company’s stock.

USANA Health Sciences Trading Down 0.6%

Shares of USNA opened at $31.72 on Wednesday. The firm has a market capitalization of $579.52 million, a P/E ratio of 17.62, a price-to-earnings-growth ratio of 1.01 and a beta of 0.64. The stock’s fifty day simple moving average is $31.19 and its 200 day simple moving average is $29.58. USANA Health Sciences, Inc. has a twelve month low of $23.10 and a twelve month high of $41.83.

USANA Health Sciences (NYSE:USNA) last issued its earnings results on Tuesday, July 22nd. The company reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.20. USANA Health Sciences had a return on equity of 9.48% and a net margin of 3.79%.The business had revenue of $235.85 million for the quarter, compared to analyst estimates of $225.20 million. USANA Health Sciences has set its FY 2025 guidance at 2.350-3.000 EPS. Sell-side analysts predict that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Insider Activity

In other USANA Health Sciences news, insider David Mulham Mulham sold 3,515 shares of the firm’s stock in a transaction dated Wednesday, July 30th. The stock was sold at an average price of $30.26, for a total value of $106,363.90. Following the transaction, the insider directly owned 9,260 shares of the company’s stock, valued at $280,207.60. This trade represents a 27.51% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Gilbert A. Fuller sold 1,058 shares of the firm’s stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $29.10, for a total value of $30,787.80. The disclosure for this sale can be found here. Insiders sold 5,073 shares of company stock worth $151,982 over the last three months. 0.63% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded USANA Health Sciences from a “hold” rating to a “buy” rating in a report on Thursday, May 22nd. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $36.00.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.